Accession Number: | 0001192482-21-000492 |
Date: | 2021-06-02 |
Issuer: | TELA BIO, INC. (TELA) |
Original Submission Date: |
O'BRIEN FEDERICA F.
C/O TELA BIO, INC.
1 GREAT VALLEY PARKWAY, SUITE 24
MALVERN, PA 19355
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 13.16 | 2021-06-02 | deemed execution date | A | 10,825 (a) | 2031-06-02 | common stock 10,825 | $13.16 | 10,825 | direct |
ID | footnote |
---|---|
f1 | the option vests on the earlier of (a) june 2, 2022, (b) the next annual meeting of stockholders, or (c) the occurrence of a change in control (as defined in the issuer's amended and restated 2019 equity incentive plan), in each case subject to the reporting person's continued service through the applicable vesting date. |